Test 1 Flashcards

(37 cards)

1
Q

When did cGMP become prevelent

A

K-Harris Amendments 1962

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is ISO internal market certification

A

Increased market share
Higher quality
Reduced customer quality audits
Greater competition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Evidence based decision making is what

A

Sound Quality management principle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Technical requirements for the registration of pharmaceutical for human use is what

A

Main objective of ICH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ISO provides what

A

Standardization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ICH guidelines that cover cGMP followed in the manufacture of AIP are found where

A

ICHQ7A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the primary focus of QMP

A

To meet or exceed customer expectations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is design validation?

A

involves ensuring the design conforms to it’s intended use by testing performance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The FDA’s CDRH compliance inspection which one is the most important

A

management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Component of design control that involves – Large scale to small scale translations

A

Design Transfer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CFR 211 PART 820

A

cGMP pharmaceuticals, quality system regulation for devices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

device history and the master record have what in common?

A

Procedures and specifications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

the consideration of human factor in device design

A

Design Input

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Center for Device and Radiological Health

A

CDRH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Design and Dev. Planning

A

involves assigning personnel and responsibilities ans setting timeline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is pre-market authorization

A

is required if a new device is not substantially equivalent to other devices and has not passed the 510K process

17
Q

Most critical parameters for assisting purity

A

Cleaning procedures

18
Q

Clinical Trial phase that testing out if the drug product will work for it’s intended use in humans?

19
Q

What is the identity attribute of a drug

A

chemical or biological fingerprint of an active pharm. drug

20
Q

3 is the minimum number of batches to prove product and process consistency for what?

A

when submitting NDA to the FDA

21
Q

QC more than QA

A

conducts environmental monitoring

22
Q

Consistency means?

A

quality should be maintained with each of the batch or lot manufactured

23
Q

What is the stability of a drug

A

the quality of a drug does not change from the time the drug is manufactured to the time it expires

24
Q

consistency of the ongoing process

A

Documentation
continuous improvement
testing
validation

25
ICH9 has what?
contains guidelines fro quality risk management
26
Quality by design is in what portion of the ICH
ICH 8
27
reaching a max # of ____causes the FDA to shut down the drug manufacturing company
27
28
What is process risk
concerns issues that can cause the product of failed specification during manufacturing
29
What is Product risk?
issues that can affect the success of the drug in the market place
30
Smoke studies
Hospira
31
bio burden
Alexicon
32
What is the 80/20 rule
avoid 80% of the fails by addressing 20% of the causes
33
What is Risk Mitigation
reduce or minimize the risk
34
What is detection
(check quiz 4 Q8)
35
Severity does what?
Measures the hazards to patients health
36
FMEA
Failure modes and Effect Analysis
37
A process that involves stating the product requirements and the assessing ways by which the product may fail
FMEA